Home Latest News Family Fitness Nutrition Healthy Aging Mental Health
Live Markets
Loading markets...
Fitness

Skin checks reveal a high percentage of 'harmless' melanomas

Thumbnail
By Josh Piers - June 17, 2022 - 5 Mins Read
melanomaskin cancer
Thumbnail
Josh Piers

Related posts

Gyms as Health Clinics: The Rise of
Gyms as Health Clinics: The Rise of 'Medical Fitness' and Biological Age Tracking in 2026
February 23, 2026
Why
Why 'Japanese Walking' Is 2026’s Biggest Viral Fitness Trend: The Science Behind the Surge
February 22, 2026
New MRI Breakthrough: Aerobic Exercise Can Reverse Brain Age by 1 Year
New MRI Breakthrough: Aerobic Exercise Can Reverse Brain Age by 1 Year
February 22, 2026
Japanese Walking Boom: Why 2026’s Ultimate Fitness Trend Is Going Viral
Japanese Walking Boom: Why 2026’s Ultimate Fitness Trend Is Going Viral
February 21, 2026

Recent Posts

Editors Picks

Genetic Breakthrough: APOE Gene Linked to 90% of Alzheimer Healthy Aging
Genetic Breakthrough: APOE Gene Linked to 90% of Alzheimer's Cases
By Jaden Francis - February 23, 2026 - 5 Mins Read
Breaking: New study links APOE gene to 90% of Alzheimer's cases, implicating the common ε3 variant and revolutionizing prevention strategies for 2026.
U.S. Measles Crisis: SC Cases Near 1,000 as Texas Outbreaks Spread Family
U.S. Measles Crisis: SC Cases Near 1,000 as Texas Outbreaks Spread
By Abi Gibson - February 23, 2026 - 5 Mins Read
US measles crisis deepens as South Carolina cases near 1,000 and new outbreaks hit Texas detention centers. CDC issues urgent alert for parents.
Why Fitness
Why 'Japanese Walking' Is 2026’s Biggest Viral Fitness Trend: The Science Behind the Surge
By Abi Gibson - February 22, 2026 - 5 Mins Read
Japanese interval walking has exploded as 2026's top fitness trend. Discover the science behind the 3-minute fast/slow method that boosts longevity.
FDA Approves BYSANTI: Breakthrough for Bipolar I & Schizophrenia Mental health
FDA Approves BYSANTI: Breakthrough for Bipolar I & Schizophrenia
By Christian Webster - February 22, 2026 - 5 Mins Read
FDA approves BYSANTI (milsaperidone) for Bipolar I and Schizophrenia. This dual-molecule breakthrough from Vanda Pharmaceuticals hits the market in 2026.